Sarepta Therapeutics Inc (NASDAQ:SRPT)

CAPS Rating: 3 out of 5

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

Recs

0
Player Avatar naughtyguy (33.88) Submitted: 10/3/2012 11:49:37 AM : Underperform Start Price: $38.17 SRPT Score: +34.13

still need phase lll

Featured Broker Partners


Advertisement